mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |